Frequently asked questions
This section covers all the questions that we were asked during the OMC. It will be updated regularly with answers to your questions.
The suppliers are free to decide the form of their participation in the tender. Even tenders from a single entity can be submitted. More info on the eligibility criteria will be included in the Call for Tenders.
Yes. More info on the eligibility criteria will be included in the Call for Tenders.
Yes, provided that they can act as market players, meaning that they can provide R&D services against payment and they can invoice the procurers for this provision of services. More info on the eligibility, selection and the on/off award criteria will be included in the Call for Tenders.
The offers will be evaluated at least by all five procuring authorities that take part in this joint procurement. More info on the evaluation procedure will be included in the Call for Tenders. See also Q26.
International collaboration between market players/potential suppliers is to be decided by the suppliers. However, this is not a prerequisite set by the call for tenders. Each tender will be evaluated on its own merits. More info on the eligibility/selection/award criteria will be included in the Call for Tenders.
The INCAREHEART PCP phase I is expected to be launched in July 2022.
All presentations and all relevant information will be published on the INCAREHEART project website.
The PCP process involves only testing the solution for usability and usefulness by users, but not certification. If the solution uses device or scales to measure clinical parameters, they must already be validated.
